{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:13:09Z","timestamp":1790363589633,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Oxford Nuffield"},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/13\/1\/30181"],"award-info":[{"award-number":["RE\/13\/1\/30181"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Oxford NIHR Biomedical Research Centre"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ijcard.2018.06.099","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T16:33:34Z","timestamp":1529944414000},"page":"253-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases"],"prefix":"10.1016","volume":"270","author":[{"given":"Ntobeko A.B.","family":"Ntusi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane M.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3583-1571","authenticated-orcid":false,"given":"Emily","family":"Sever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan K.","family":"Piechnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Wordsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Neubauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros D.","family":"Karamitsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.ijcard.2018.06.099_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/rheumatology\/39.suppl_2.3","article-title":"Epidemiology of rheumatic diseases","volume":"39","author":"Sangha","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.ijcard.2018.06.099_bb0010","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(13)61499-3","article-title":"Clinical aspects of autoimmune rheumatic diseases","volume":"382","author":"Goldblatt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2018.06.099_bb0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/art.10705","article-title":"Survival in rheumatoid arthritis: a population-based analysis of trends over 40\u202fyears","volume":"48","author":"Gabriel","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0020","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjmed.2005.11.034","article-title":"Long-term prognosis and causes of death in systemic lupus erythematosus","volume":"119","author":"Doria","year":"2006","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0025","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1161\/CIRCULATIONAHA.106.678334","article-title":"Cardiovascular manifestations of rheumatologic diseases","volume":"116","author":"Roman","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.06.099_bb0030","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2147\/VHRM.S2453","article-title":"Cardiovascular morbidity in rheumatic diseases","volume":"4","author":"Turesson","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0035","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.mehy.2003.11.040","article-title":"Rheumatoid arthritis increases the risk of coronary heart disease via vascular endothelial injuries","volume":"63","author":"Wang","year":"2004","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.ijcard.2018.06.099_bb0040","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nrd2196","article-title":"Biologic therapies in rheumatology: lessons learned, future directions","volume":"6","author":"Strand","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0045","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/08830189809084493","article-title":"Cytokines and autoimmune disorders","volume":"17","author":"Feldmann","year":"1998","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/rheumatology\/41.3.329","article-title":"The role of TNF-\u03b1 in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA\/SCID mouse chimera","volume":"41","author":"Matsuno","year":"2002","journal-title":"Rheumatology"},{"key":"10.1016\/j.ijcard.2018.06.099_bb0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0163-7258(02)00176-6","article-title":"Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor alpha therapy in heart disease","volume":"94","author":"Sack","year":"2002","journal-title":"Pharmacol. Ther."},{"issue":"6","key":"10.1016\/j.ijcard.2018.06.099_bb0060","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1136\/annrheumdis-2013-205058","article-title":"Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis","volume":"74","author":"del Rinc\u00f3n","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.ijcard.2018.06.099_bb0065","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/art.39098","article-title":"Disease activity in rheumatoid arthritis and the risk of cardiovascular events","volume":"67","author":"Solomon","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0070","first-page":"1213","article-title":"Treatment with TNF-blockers and mortality risk in patients with rheumatoid arthritis","volume":"32","author":"Jacobsson","year":"2007","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0075","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","article-title":"Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis","volume":"106","author":"Hurlimann","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.06.099_bb0080","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2383","article-title":"Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study","volume":"10","author":"Naranjo","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0085","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.22809","article-title":"Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis \u03b1 therapy: results from the British Society for Rheumatology Biologics Register","volume":"56","author":"Dixon","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00296-009-0935-2","article-title":"Long-term anti-tumour necrosis factor therapy reverses the progression of carotid intima-media thickness in female patients with active rheumatoid arthritis","volume":"30","author":"Ferrante","year":"2009","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0095","first-page":"155","article-title":"Lack of association between carotid intima-media wall thickness and carotid plaques and markers of endothelial cell activation in rheumatoid arthritis patients undergoing anti-TNF therapy","volume":"37","author":"Gonzalez-Gay","year":"2012","journal-title":"Acta Rheumatol. Port."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0100","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/rheumatology\/ker434","article-title":"Anti-TNF-\u03b1 therapy may not improve arterial stiffness in patients with AS: a 24-week follow-up","volume":"51","author":"Capkin","year":"2012","journal-title":"Rheumatology"},{"key":"10.1016\/j.ijcard.2018.06.099_bb0105","first-page":"505","article-title":"Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation","volume":"47","author":"Antoni","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0110","doi-asserted-by":"crossref","first-page":"R439","DOI":"10.1186\/ar1693","article-title":"Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3\u202fyears of continuous treatment with infliximab","volume":"7","author":"Baraliakos","year":"2005","journal-title":"Arthritis Res. Ther."},{"issue":"5","key":"10.1016\/j.ijcard.2018.06.099_bb0115","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.24492","article-title":"Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis","volume":"60","author":"van Eijk","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0120","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.06.099_bb0125","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with chronic heart failure: results of the randomized etanercept worldwide evaluation (RENEWAL)","volume":"109","author":"Mann","year":"2004","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcard.2018.06.099_bb0130","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jcmg.2014.12.025","article-title":"Diffuse myocardial fibrosis and inflammation in rheumatoid arthritis: insights from CMR T1 mapping","volume":"8","author":"Ntusi","year":"2015","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2018.06.099_bb0135","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jcmg.2013.01.011","article-title":"T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique","volume":"6","author":"White","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2018.06.099_bb0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1532-429X-16-21","article-title":"Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis \u2013 a clinical study using myocardial T1 mapping and extracellular volume quantification","volume":"16","author":"Ntusi","year":"2014","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0145","doi-asserted-by":"crossref","first-page":"I350","DOI":"10.1161\/hc37t1.094851","article-title":"Myocardial protection and vascular biology: inhibition of tumor necrosis factor \u03b1 improves post-ischemic recovery of hypertrophied hearts","volume":"104","author":"Stamm","year":"2001","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2018.06.099_bb0150","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5830\/CVJA-2014-036","article-title":"Infliximab, an anti-tumor necrosis factor alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results","volume":"25","author":"\u00c7etin","year":"2014","journal-title":"Cardiovasc. J. Afr."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0155","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1378\/chest.101.3.810","article-title":"Administration of anti-TNF antibodies improves left ventricular function in septic shock patients. Results of a pilot study","volume":"101","author":"Vincent","year":"1992","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2018.06.099_bb0160","article-title":"Treatment with biological agents improves endothelial and coronary artery function in parallel with left ventricular deformation and twisting in patients with psoriasis","volume":"128","author":"Ikonomidis","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.06.099_bb0165","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/eurheartj\/ehp205","article-title":"Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease","volume":"30","author":"Recio-Mayoral","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0170","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/HYPERTENSIONAHA.109.143982","article-title":"Tumour necrosis factor-alpha antagonists improve aortic stiffness in patients with inflammatory arthropathies: a controlled study","volume":"55","author":"Angel","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2018.06.099_bb0175","first-page":"373","article-title":"Influence of anti-TNF-\u03b1 infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis","volume":"24","author":"Gonzalez-Gay","year":"2006","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0180","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/s10165-007-0605-8","article-title":"Anti-tumor necrosis factor therapy increases serum adiponectin levels with the improvement of endothelial dysfunction in patients with rheumatoid arthritis","volume":"17","author":"Komai","year":"2007","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0185","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.4049\/jimmunol.163.3.1521","article-title":"Regulation of cytokines, cytokine inhibitors and acute phase proteins following anti-TNF-\u03b1 therapy in rheumatoid arthritis","volume":"163","author":"Charles","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijcard.2018.06.099_bb0190","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.20217","volume":"50","author":"Keystone","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.ijcard.2018.06.099_bb0195","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/rheumatology\/kep426","article-title":"Towards understanding the phenotypes of myocardial involvement in the presence of self-limiting and sustained systemic inflammation: a magnetic resonance imaging study","volume":"49","author":"Puntmann","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ijcard.2018.06.099_bb0200","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.febslet.2007.11.051","article-title":"TNF-\u03b1 and adipocyte biology","volume":"582","author":"Cawthorn","year":"2008","journal-title":"FEBS Lett."},{"issue":"12","key":"10.1016\/j.ijcard.2018.06.099_bb0205","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/clc.22332","article-title":"Evaluation of ascending aorta wall in rheumatoid srthritis by tissue and strain Doppler imaging during anti-tumor necrosis factor \u03b1 therapy","volume":"37","author":"Vizzardi","year":"2014","journal-title":"Clin. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2018.06.099_bb0210","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ajh.2012.12","article-title":"Effect of 1-year anti-TNF-\u03b1 therapy on aortic stiffness, carotid atherosclerosis, and calprotectin in inflammatory arthropathies: a controlled study","volume":"25","author":"Angel","year":"2012","journal-title":"Am. J. Hypertens."},{"issue":"11","key":"10.1016\/j.ijcard.2018.06.099_bb0215","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.105.601641","article-title":"Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-\u03b1 therapy","volume":"114","author":"M\u00e4ki-Pet\u00e4j\u00e4","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2018.06.099_bb0220","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/03009740802363768","article-title":"Sustained improvement of vascular endothelial function during anti-TNF-\u03b1 treatment in rheumatoid arthritis patients","volume":"38","author":"Sidiropoulos","year":"2009","journal-title":"Scand. J. Rheumatol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317372108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527317372108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T07:26:39Z","timestamp":1717226799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527317372108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":44,"alternative-id":["S0167527317372108"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.06.099","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-TNF modulation reduces myocardial inflammation and improves cardiovascular function in systemic rheumatic diseases","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.06.099","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}